C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/861 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2291356
A recombinant, adenoviral vector is described, which still has the capability of autoreplication of the vector DNA after partial deletion of the E1 region, but can no longer form infectious virus particles. This vector can carry a transgenic DNA sequence for a therapeutically active gene and can be employed in somatic gene therapy, the transgene stability compared with vectors without the capability of autoreplication being significantly increased.
Aventis Behring Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Centeon Pharma Gmbh
LandOfFree
Recombinant, adenoviral vector having limited... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant, adenoviral vector having limited..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant, adenoviral vector having limited... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1621358